News & Insights

BioPhorum Sustainability introduces a new tool to improve monitoring of heating, ventilation and air conditioning (HVAC) systems for more sustainable manufacturing practices. 

Swiss pharma giant secures access to Korean biotech's ALT-B4 hyaluronidase platform in milestone-heavy agreement, marking Alteogen's fourth major licensing deal of 2026 as competition intensifies in the subcutaneous drug delivery space.

In this latest instalment of our Women in Pharma series, we sit down with Clarissa Sowemimo-Coker, Chief Strategy Officer at Ambrose Healthcare and CPHI Middle East Advisory Board Member.

About the Pharmaceutical Supply Chain Initiative The Pharmaceutical Supply Chain Initiative (PSCI) is the leading, member-led association for pharmaceutical companies working collaboratively to build responsible supply chains. Founded in 2006 and es...

Britain's largest drugmaker lost more than GBP£17 billion in market value following reports of preliminary merger discussions with Bristol Myers Squibb that could create a pharmaceutical giant worth nearly US$400 billion, though investors rem...

Pharmaceutical giant to establish flagship research facility on Cambridge Biomedical Campus as part of strategic pipeline acceleration

The Report Was Never the Destination - “The future of pharmaceutical sustainability won’t be shaped by individual organisations working in isolation. It will be shaped by partnerships, shared expertise and the willingness to work diffe...

The US president has announced plans to impose tariffs of up to 200% on imported generic medicines from August 2028, giving manufacturers a two-year window to establish domestic production facilities. The move threatens to upend a global supply chain t...

The Pharmaceutical Supply Chain Initiative (PSCI) has released its seventh annual Audit Findings Analysis Report, offering unprecedented insights into supplier practices across the global pharmaceutical and healthcare industry.With a record-breaking 24...

A US federal court has halted Colorado's attempt to impose a US$31,200 annual price cap on Amgen's arthritis drug Enbrel, ruling that the pharmaceutical company would likely suffer irreparable harm. The decision represents a significant blow to...

The pharmaceutical contract development and manufacturing organisation (CDMO) sector is experiencing unprecedented transformation, driven by evolving therapeutic complexities, geopolitical tensions, and the growing demand for specialised manufacturing ...

The latest episode of the CPHI Podcast Series dives into a critical challenge facing the pharmaceutical industry: ensuring the integrity of temperature-sensitive medications and biologics through advanced predictive technology.

Pharmaceutical giant Roche has reaffirmed its commitment to investing in Germany, standing firm even as competitors Eli Lilly and Boehringer Ingelheim dramatically reduce their planned investments in response to controversial healthcare reforms.

Our monthly Women in Pharma series highlights the influential lives and work of impactful women working across the pharmaceutical industry, and how the industry can work towards making the healthcare industry and workplace more equitable and inclusive.

Our From the Floor live blog returns to Philadelphia for CPHI Americas 2026, continuing to showcase the entire pharmaceutical supply chain from north to south across the Americas.

In this exclusive interview, Jim Donovan, VP and General Manager of Pfizer CentreOne, shares real-world insights on navigating the toughest challenges in ADC and biologics manufacturing: from high-containment conjugation and accelerated tech trans...

European negotiators have agreed new legislation to tackle persistent shortages of essential medicines by prioritising supply security over price in public procurement and supporting domestic pharmaceutical manufacturing with strategic funding.

The life sciences giant is divesting its global microbiology unit, which generated $645 million in revenue last year, to the pan-European private equity firm as part of an active portfolio management strategy. The transaction is expected to close in th...

CPHI Online contributor David Roach takes a look at how conversations around sustainability in the pharmaceutical industry can and must be transformed into actionable deliveries, and what the inaugural CPHI Sustainability Summit means for the industry.

Boehringer Ingelheim has unveiled a cutting-edge AI Accelerator in London’s Knowledge Quarter, marking a significant step in computational innovation and the future of pharmaceutical research.

Our monthly Women in Pharma series highlights the influential lives and work of impactful women working across the pharmaceutical industry, and how the industry can work towards making the healthcare industry and workplace more equitable and inclusive.

Anil Kane, PhD, MBA, serves as the Executive Director and Global Head of Technical & Scientific Affairs at Thermo Fisher Scientific, a global leader in scientific research and innovation. In this exclusive interview, Kane shares his and Thermo Fisher&#...

Amazon Web Services (AWS) has introduced Amazon Bio Discovery, a new platform designed to harness AI in the field of drug discovery. The initiative aims to address the challenges of lengthy and expensive drug development processes by providing research...

The Swiss pharmaceutical sector has raised alarms over new US tariffs on medicines, warning of disrupted supply chains, increased costs, and delayed innovation, all of which could jeopardise patient access to essential treatments worldwide.

India’s pharmaceutical industry has emerged as a significant player in the global market, valued at USD 50 billion in FY 2023-2024, according to Frost & Sullivan’s analysis. This sector encompasses a diverse portfolio, including drugs, vacc...

Biogen Inc. has announced its acquisition of Apellis Pharmaceuticals, Inc., a move that is set to significantly enhance its growth portfolio in immunology and rare diseases. The agreement, valued at approximately US$5.6 billion, will see Biogen purchas...

From February 23–28, CPC1 Hanoi proudly completed three international shipments, reinforcing our expanding global footprint and strong export momentum.We welcome partnership discussions for distribution and export opportunities worldwide.

...

Gilead Sciences confirms a deal to take over Ouro Medicines, adding to a portfolio of therapies for autoimmune diseases. 

In a world first, a China-based biotech company, Unixell Biotechnology, has been granted permission to test a kind of epilepsy therapy in humans. 

Discover the latest innovations in technologies and therapeutics that are revolutionising women's health in our latest CPHI Online Women in Pharma infographic.

The series aims to highlight some of the indispensable talent involved in all aspects of the pharma value chain, getting to know the people working towards better healthcare across the world. This special edition aims to get to know the people attendin...

Submissions now open — deadline May 16

In an industry where precision and sterility are crucial concerns, cleanrooms play a vital role in maintaining the integrity of pharmaceutical products like drugs, vaccines, and other medical products. So, what is a cleanroom?

Dr Reddy’s Laboratories, one of India’s leading pharmaceutical companies, is preparing to launch a generic version of semaglutide, branded as Obeda, in March. Obeda is expected to provide a more affordable alternative to Ozempic a...

Frontier Biotechnologies and GSK have entered a global licensing agreement to advance small interfering RNA (siRNA) therapeutics. This collaboration grants GSK exclusive rights to develop and commercialise two promising siRNA candidates, marking a mile...

Our monthly Women in Pharma series highlights the influential lives and work of impactful women working across the pharmaceutical industry, and how the industry can work towards making the healthcare industry and workplace more equitable and inclusive.

Eli Lilly and Co. is positioning India as a key player in its global supply chain, driven by the booming success of its diabetes and obesity drug, Mounjaro.

This special Pharmapack episode of our podcast, recorded live at Pharmapack 2026, interviews Terence O’Hagan, Vice President of Business Development for Drug Delivery Systems at Stevanato Group, sharing exclusive insights into the company’s...

The Day in the Life of series continues with a spotlight on those in the R&D side of things in pharma, a key element to medicine discovery, safety, and manufacture. This interview shines a light on those working in this integral field. 

A Reflection on the Sustainability Collective Roundtable Session at Pharmapack 2026

The company plans to create more than 2,800 manufacturing and construction jobs at Lilly's 10th US manufacturing site announced since 2020. 

Landmark investment will expand AstraZeneca’s capabilities to discover, develop, and manufacture transformative new treatments in China, contributing to AstraZeneca's 2030 goals. 

The following infographic outlines key drugs that have been newly approved by the US FDA in 2025.

The latest appointments, promotions, and structural changes across the pharmaceutical supply chain.

In 2026 we are continuing with the Day in the Life Of series, where we interview the people behind the medicines and find out what drives them, and how they go to where they are today. The series gives a personal insight into what it's like to work...

The 2026 Pharmapack Awards, held January 21, 2026, celebrated and recognised leading companies in the pharmaceutical packaging sector paving the way for packaging and drug delivery excellence in the future. 

Celebrating its 25th anniversary in the city where it all started, Pharmapack 2026 is back in Paris! From January 21-22, 2026, Paris Expo Porte de Versailles opens its doors again to the pharmaceutical packaging and drug delivery sectors, ready for 2 d...

For 25 years, Pharmapack has been at the forefront of innovation, collaboration, and progress in the pharmaceutical packaging and drug delivery industry. From its humble beginnings to becoming a global hub for industry leaders, the event has witnessed ...

Citeo PRO is transforming professional packaging with innovative solutions, collective action, and a dedication to sustainability within the pharmaceutical sector. Discover how they are supporting companies at Pharmapack 2026 in this interview with Dom...

Paris, 2026. The doors to Portes de Versailles Expo Centre are open, with Pharmapack attendees, exhibitors, and speakers streaming through as the day begins with anticipation. You adjust your visitor’s lanyard, clutch a much-needed...

Pharmapack 2026 marks a significant milestone as it celebrates its 25th anniversary, bringing together global leaders in pharmaceutical packaging and drug delivery. In this exclusive interview, Ypsomed, a pioneering developer and manufacturer of subcut...

Acquisition brings an advanced, highly differentiated treatment for prostate cancer, strengthening Johnson & Johnson’s longstanding commitment to innovation in the disease. Lead asset demonstrates potential to overcome key resistance pathways ...

We feature the most popular articles published on CPHI Online from 2025, ranging from blockbuster news over GLP-1 therapies, including discussions with experts on the subject, to some of our regular interview series features, and content surrounding ou...

The PSCI releases its annual Audit Findings Analysis, providing continued insights into supplier risks, trends, and areas for improvement across the pharmaceutical and healthcare supply chain.  Health & Safety remains a central topic with Gover...

On site in the Messe Frankfurt for CPHI Frankfurt 2025 we had the chance to interview some of the speakers in the conference theatre, including Vera Carvalho Correia, Global ESG Senior Manager at Centrient Pharmaceuticals. 

Our monthly Women in Pharma series highlights the influential lives and work of impactful women working across the pharmaceutical industry, and how the industry can work towards making the healthcare industry and workplace more equitable and ...

Recursion Pharmaceuticals has announced promising results from its ongoing early- to mid-stage trial evaluating its AI-powered treatment, REC-4881, for familial adenomatous polyposis (FAP).

Novo Nordisk A/S: Evoke phase 3 trials did not demonstrate a statistically significant reduction in Alzheimer's disease progression, leading to a discontinuation in the trials' one-year extension period. 

Welcome to this special on-site episode of our podcast, recorded live at CPHI Frankfurt 2025. The following episode encapsulates the key themes that were discussed at CPHI Frankfurt this year. 

This month's Day in the Life of interview looks a little different! After a successful week at CPHI Frankfurt, we catch up with one of our exhibitors to get a peak behind the scenes and see how they spend their days on site. 

This interview captures a snapshot into what it is like for a Start-Up company attending CPHI Frankfurt for the first time, under the Start-Up Programme the event has been running for the last couple of years, and what this means to the people beh...

Pharmapack 2026 returns as the pharmaceutical packaging industry's premier gathering, bringing together global leaders, innovators, and decision-makers for an unparalleled showcase of cutting-edge solutions and strategic insights.

CPHI Celebration was held on the first night of CPHI Frankfurt 2025 in October 2025, whereby pre-eminent pharma players came together to recognise winners of the 2025 CPHI Pharma Awards.

Lilly plans to build a new $3 billion facility to boost oral medicine manufacturing capacity in Europe for patients worldwide.

The Sustainability Collective from CPHI unveils the groundbreaking Pharmaceutical Sustainability Ecosystem to drive pharmaceutical knowledge sharing, connection, and collaboration in order to change the face of sustainability in pharmceutical...

In a full-circle moment, our From the Floor blog returns to Frankfurt for the 2025 edition of CPHI Frankfurt. Taking place over 3 days from 28–30 October, we're excited to be back in a city of global innovation to meet, collaborate, and grow ...

Explore what the CPHI community has to say about the top trends emerging from the pharmaceutical industry and supply chain with our annual Strategic Insights infographic. 

In the following interview, dsm-firmenich shows how they are leading the way in pharmaceutical sustainability by addressing key challenges, aligning with the UN SDGs, and driving innovative solutions to build resilient supply chains and reduce env...

The latest episode of the CPHI Podcast Series delves into the future of obesity management globally, offering opinins on might happen after patent expirys and new globals players entering the fray. 

Discover key insights into the future of pharmaceutical events and explore how CPHI is shaping industry collaboration through tailored, innovative event experiences in this infographic. 

The pharmaceutical industry is witnessing a seismic shift as major companies embrace direct-to-consumer sales models and announce significant price reductions across the United States, responding to mounting pressure from the Trump administration to ta...

CPHI Frankfurt, to be held at Messe Frankfurt from October 28-30, 2025, will once again bring the pharmaceutical industry together for 3 days of collaboration and innovation. Our Track Sponsor interview series sits down with some of our conference trac...

In our Day in the Life of series we love getting to know the people at the heart of pharma. In this latest interview we speak to Sanobar Syed, Senior Director at Boehringer Ingelheim, about her career and what she feels is most important for the f...

The US Congress reached a deadlock after not being able to come to an agreement regarding funding, specifically reaching an impasse when Republicans and Democrats were unable to reach an agreement regarding Obamacare subsidies. The resulting shutdown o...

This episode explores how AI is revolutionising the pharmaceutical industry, from "smart factories" to seamless supply chain integration, and discuss the transformative advancements shaping the next decade.

This interview with consultants, CCD Partners, explores the evolving investment landscape in the pharmaceutical industry, highlighting challenges for smaller firms, the growing focus on sustainability and biologics, and the increasing role of AI and re...

Pharmacy benefit managers (PBMs) are currently developing a proposal to voluntarily modify certain business practices in an effort to avoid new regulations from the Trump administration, according to sources familiar with the ongoing discussions.

Our monthly Women in Pharma series highlights the influential lives and work of impactful women working across the pharmaceutical industry, and how the industry can work towards making the healthcare industry and workplace more equitable and inclusive.

CPHI Frankfurt, to be held at Messe Frankfurt from October 28–⁠30, 2025, will once again bring the pharmaceutical industry together for 3 days of collaboration and innovation. Our interview series sits down with some of our conference track ...

AstraZeneca, Britain's largest company by market capitalisation, has paused its planned GBP£200 million investment in its Cambridge research site, marking the latest in a series of pharmaceutical industry retreats from the UK.

You’ve bought your CPHI Frankfurt pass and booked your flights (or trains!) and hotel for one of Europe’s major financial hubs. You’re excited to walk the CPHI Frankfurt show over 3 days, meeting new people, collaborating with innovat...

CPHI Frankfurt, to be held at Messe Frankfurt from October 28–⁠30, 2025, will once again bring the pharmaceutical industry together for 3 days of collaboration and innovation. Our Track Sponsor interview series sits down with some of our conferen...

VERDOT’s new sustainable headquarters and manufacturing facility in Riom reflects its commitment to operational efficiency, environmental sustainability, and innovation. In the following interview, VERDOT CEO Charles Ruban discusses this new vent...

CPHI Frankfurt, to be held at Messe Frankfurt from October 28–⁠30, 2025, will once again bring the pharmaceutical industry together for 3 days of collaboration and innovation. Our Track Sponsor interview series sits down with some of our conferen...

Our monthly Women in Pharma series highlights the influential lives and work of impactful women working across the pharmaceutical industry, and how the industry can work towards making the healthcare industry and workplace more equitable and inclusive.

AbbVie has penned a significant agreement to acquire the bretisilocin programme from Gilgamesh Pharmaceuticals for up to £1.2 billion, marking a bold step in the pharmaceutical giant's quest to develop treatments for psychiatric disorders.

CPHI Frankfurt, to be held at Messe Frankfurt from October 28-30, 2025, will once again bring the pharmaceutical industry together for 3 days of collaboration and innovation. Our Track Sponsor interview series sits down with some of our conference trac...

The Sustainability Report 2025: Strategies for responsible pharma leadership –provides an in-depth exploration of the pharmaceutical industry's most critical sustainability challenges, highlighting innovative solutions through practical case ...

Johnson & Johnson announce plans to further their investment into reshoring in the US by adding a new manufacturing facility in North Carolina, USA, at FUJIFILM's new biomanufacturing site. 

This is a feature article written by Nick Fryer, Vice President of Marketing, Sheer Logistics

CPHI Frankfurt, to be held at Messe Frankfurt from October 28-30, 2025, will once again bring the pharmaceutical industry together for 3 days of collaboration and innovation. Our Track Sponsor interview series sits down with some of our conference trac...

In the latest episode Lucy Chard engages in a compelling conversation with Dr Lengwe Sinkala, a seasoned clinician and Human Factors and User Experience Consultant at ClariMed. 

Building on its success in developing continuous production at pilot-scale with the WuXiUP™ platform, WuXi Biologics has further enhanced the technology to achieve automated continuous drug substance (DS) manufacturing at pilot-scale.

Ecolab expert Renato Azevedo shares his insights on the current state of the biosimilars market in pharmaceuticals, after a high number of biosimilar drug approvals throughout the year confirming the shift of focus in this field.   

The US Food and Drug Administration (FDA) has announced a new initiative aimed at strengthening America's pharmaceutical supply chain through increased regulatory predictability and streamlined processes for constructing manufacturing facilities on...

The Bill & Melinda Gates Foundation has announced a substantial US$2.5 billion commitment to accelerate research and development focused exclusively on women's health through 2030.

The latest feature from the PSCI updates on the protection of Horseshoe Crabs and ensuring responsible pharmaceutical practices. The pharmceutical industry relies on these crabs to ensure the safety of several medicines, putting the species at risk.&nb...

Bristol-Myers Squibb (BMS) and Bain Capital have established a new independent biopharmaceutical company focused on developing innovative therapies for autoimmune diseases, the companies announced on Monday.

Our monthly Women in Pharma series highlights the influential lives and work of impactful women working across the pharmaceutical industry, and how the industry can work towards making the healthcare industry and workplace more equitable and inclusive.

British pharma giant announces substantial manufacturing and R&D expansion as industry responds to reshoring pressures

In this Day in the Life of interview, Thomas Hauser, Director of Business Development at Tjoapack. Thomas has spent nearly 30 years in the pharmaceutical industry and describes how he still finds curiosity and excitement in the bigger picture of global...

Since the inception of the CPHI Online Women in Pharma series, we have had the privilege of meeting and learning from women leaders across the pharmaceutical value chain. Many of these conversations have sparked similar themes around authenticity, cour...

Transcend Therapeutics receives Breakthrough Therapy Designation from the USA FDA for TSND- 201 (methylone) for the treatment of PTSD, after positive results from the Phase II clinical trial, IMPACT-1. 

As we fly past the halfway point of 2025, the pharmaceutical landscape reliably continues to evolve with innovative therapies addressing critical medical needs. The FDA has already approved 17 groundbreaking medications this year, each representin...

The pharmaceutical industry is facing a sustainability revolution, with new data from the Pharmapack 2025 Strategic Insights & Research survey highlighting both progress and persistent obstacles across the sector.

As part of our CPHI Americas conference sessions, we held a closed roundtable bringing together top pharmaceutical industry experts and thought leaders to discuss the most pertinent issues and trends surrounding the whole of the American pharmaceutical...

This year’s CPHI Women event was held on 10 April 2025 inside the CPHI Japan venue adjacent to Tokyo Big Sight. Now in its 9th edition, CPHI Women aims to foster networking opportunities for women working in the pharmaceutical industry in Japan.

The 2025 ISPE Europe Annual Conference was held May 12-14, 2025 in London, UK, bringing together a community of pharmaceutical engineers and professionals from all industry levels to discover the latest in pharmaceutical technologies and innovations.&n...

The European Commission, the primary executive arm of the EU, announced their decision to exclude Chinese companies from EU government purchases of medical devices exceeding EUR€5 million in a bid to rebalance trade barriers.

The US FDA announced a new priority program for drug developers – the Commissioner’s National Priority Voucher (CNPV) program aims to enhance the health interests of the US by allowing drug developers to redeem a voucher, shortening th...

Anglo-Swedish pharmaceutical giant AstraZeneca announced they have signed a deal with China’s CSPC Pharmaceutical Group worth up to US$5.3 billion to drive AI-led research development of therapies for chronic conditions.

While CPHI Americas 2025 has wrapped, the learnings from on-site don’t stop. From exclusive interviews with leading industry experts, we bring you our Insider Insights from the Philadelphia show floor.

The latest episode of the CPHI Podcast Series provides a timely overview of the recent policy changes in the USA, with President Trump signing excecutive orders to change drug pricing under a 'Most Favoured Nation' scheme.

In this month's Day in the Life of, we spend time with Katie Price, UX Design Consultant for Team Consulting. Katie leads an active life driven by compassion and a desire to improve people's lives. 

CPHI Online attended the ISPE Europe Annual Conference 2025, held May 12-14, 2025, in London, UK at the Novotel West London. Throughout 3 days of discussions and collaboration, we spoke to various experts across the life sciences and pharmaceutical eng...

In this month's Day in the Life Of interview, I spoke to Nigel Stapleton, VP of Business Development in Biopharmaceutical Contract Manufacturing for Mabion SA, about his illustrious career and some personal highlights. 

Our From the Floor live blog is back in Philadelphia for this year’s CPHI, this time under the new name CPHI Americas to embrace and represent the whole of the pharmaceutical supply chain from north to south.

Our monthly Women in Pharma series highlights the influential lives and works of impactful women working across the pharmaceutical industry, and how the industry can towards making the healthcare industry and workplace more equitable and inclusive.&nbs...

Over the weekend, President Donald Trump announced that he would be imminently signing a new executive order to cut prescription drug prices in the USA, to match those of other high-income countries. 

As we gear up for CPHI Americas from May 20-22, 2025 at the Philadelphia Convention Center, we sat down with Track Sponsor Thermo Fisher Scientific to discuss the future of bioproduction in pharma.